To increase stroke survivors' participation during the course of rehabilitation, psychosocial factors as well as biological factors should be included in a multidimensional treatment approach.
[Purpose] The purpose of this study was to investigate the psychometric properties of the
lower extremity subscale of the Fugl-Meyer Assessment lower extremity (FMA-LE) for
community-dwelling hemiplegic stroke patients. [Subjects] The participants were 140
community-dwelling hemiplegic stroke patients. [Methods] To determine the psychometric
properties of the FMA-LE, we examined construct validity, response characteristics, item
discrimination, and internal consistency. [Results] Factor analysis of the FMA-LE revealed
that the first factor explained 61.73% of the variance and provided evidence of
unidimensionality. The FMA-LE did not show ceiling or floor effects; Cronbach’s α was
0.935 (95% CI: 0.919–0.950). [Conclusion] Because the FMA-LE seems to be both valid and
reliable, we conclude that it is appropriate for the measurement of the lower extremity
motor impairment of community-dwelling hemiplegic stroke patients.
[Purpose] The purpose of this study was to investigate the psychometric properties of the
Falls Efficacy Scale using Rasch analysis in patients with hemiplegic stroke. [Subjects]
Fifty-five community-dwelling hemiplegic stroke patients were selected as participants.
[Methods] Data were analyzed using the Winsteps program (version 3.62) with the Rasch
model to confirm the unidimensionality through item fit, reliability, and appropriateness
of the rating scale. [Results] There were no misfit persons or items. Furthermore, infit
and outfit statistics appeared adjacent. The person separation value was 3.07, and the
reliability coefficient was 0.90. The reliability of all items was at an acceptable level
for patients with hemiplegic stroke. [Conclusion] This was the first study to investigate
the psychometric properties of the Falls Efficacy Scale using Rasch analysis. The results
of this study suggest that the 6-point Falls Efficacy Scale is an appropriate tool for
measuring the self-perceived fear of falling in patients with hemiplegic stroke.
Background It is reported that hopeful thinking plays a positive role in encouraging patients to achieve functional goals during the rehabilitation process. Hope is a key concept in evaluating stroke outcomes in research and rehabilitation practice. Aims The purpose of this study was to investigate the psychometric properties of the Korean Dispositional Hope Scale (K-DHS) using the Rasch analysis in patients with hemiplegic stroke. Methods The K-DHS was completed by 166 community-dwelling hemiplegic stroke patients in Korea. Data were analyzed according to item fit, item difficulty, and the appropriateness of the rating scale using the Rasch analysis. Results Item fit analysis showed that 8 items of the K-DHS are appropriate because the infit MSNQ was between 0.7 and 1.3. Item difficulty results revealed that there is a difference in distribution between personal attributes and item difficulty. It shows that the item fit statistics of the 4-point Likert scale of K-DHS are all good. The person separation index demonstrated that the K-DHS could differentiate two or three hope status strata in stroke patients. The item separation index indicated that the items were useful with high reliability. Conclusion The K-DHS comprises appropriate items for measuring the hope of stroke patients living in the community, and the rating scale of the K-DHS is also appropriate. This study is the first to conduct an analysis of the rating scale and its appropriateness, as well as the difficulty of items based on item response theory, and offers new insights for enhancing hope and improving well-being following stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.